What’s next for #biosimilars? At Amgen, continued development and manufacturing expertise is helping drive what’s ahead. Watch to learn more: amgen.ly/4eg6DdX
00:00
Amgen 🧪🔬🧬
14.1K posts
Amgen 🧪🔬🧬
@Amgen
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases.
🔗 Guidelines: amgen.ly/RpcA3B
- NC’s life sciences ecosystem is driving innovation, growth & opportunity. With more than $1.5 billion invested in the state, Amgen is proud to be part of that momentum. In @BusinessNC, Amgen's Paul Lewus shares how the Research Triangle can maintain its leadership in life
- Ohio’s thriving manufacturing hub shows what’s possible when innovation, talent, and pro-growth tax policies align. We're proud to be part of this momentum, investing more than $1.4B in Ohio to help strengthen U.S. leadership in biotech. amgen.ly/3S2ARZd
- NEWS: At #ADASciSessions 2026, we’re advancing the conversation around cardiometabolic care. New data reinforce the need for more integrated approaches to prevention, risk reduction, and long-term management across obesity, diabetes and cardiovascular disease. 🔗 Read more:
00:00 - People living with cardiometabolic conditions often face interconnected risks that can compound over time. This week at @AmDiabetesAssn’s #ADASciSessions, we’re helping advance the conversation around a more integrated approach to obesity, diabetes and cardiovascular disease and
- How will AI shape the future of Amgen? CEO Bob Bradway recently joined Sarah Elk and AI pioneer @AndrewYNg on @BainandCompany's Winning with AI podcast to discuss how AI is helping accelerate innovation across drug discovery, development, and manufacturing. 🎙️Watch the full
00:00 - 📢 Amgen announced the presentation of new data across rare autoimmune & inflammatory diseases at #EULAR2026. Research highlights IgG4-related disease & real-world evidence in ANCA-associated vasculitis. 🔗 Learn more: amgen.ly/4a8lyEu $AMGN
00:00 - Amgen announced the planned retirement of EVP and CFO Peter Griffith. Thomas Dittrich will return to Amgen and succeed Griffith as CFO effective Sept. 1, 2026. “We are grateful to Peter for his leadership and lasting impact on the company,” said Chairman and CEO Robert A.
00:00 - How do you navigate B-cell ALL at 21? After years of hospital stays & uncertainty, William is in remission. Now he’s helping other young people advocate for themselves. Read his story: amgen.ly/49pJfI3 @TheMightySite #AmgenSponsored
